(MOS) The Mosaic - Overview
Exchange: NYSE •
Country: United States •
Currency: USD •
Type: Common Stock •
ISIN: US61945C1036
Stock: Phosphate, Potash, Fertilizer, Feed Ingredients
Total Rating 32
Risk 84
Buy Signal -1.19
| Risk 5d forecast | |
|---|---|
| Volatility | 36.3% |
| Relative Tail Risk | -4.01% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.53 |
| Alpha | -4.98 |
| Character TTM | |
|---|---|
| Beta | 0.958 |
| Beta Downside | 2.030 |
| Drawdowns 3y | |
|---|---|
| Max DD | 56.98% |
| CAGR/Max DD | -0.34 |
EPS (Earnings per Share)
Revenue
Description: MOS The Mosaic March 02, 2026
The Mosaic Company (NYSE: MOS) is a vertically integrated producer and marketer of concentrated phosphate and potash nutrients, operating across three segments-Phosphates, Potash, and Mosaic Fertilizantes-and serving a global customer base that includes distributors, retailers, cooperatives, and industrial users.
In its most recent quarter (Q4 2025), Mosaic reported revenue of $5.8 billion, an EBITDA margin of 15%, and net income of $300 million, driven by the production of roughly 12 million metric tons of phosphate products and 5 million metric tons of potash. The company’s fertilizer price index rose 12% year-over-year, reflecting tight supply and strong demand.
Key drivers for Mosaic include accelerating global food demand-especially in Brazil and India-where crop acreage is expanding, and rising input costs tied to energy and raw material prices. Additionally, ESG pressures are prompting growers to adopt higher-efficiency nutrients, bolstering demand for Mosaic’s specialty blends.
For a deeper dive, see ValueRay’s detailed MOS analysis.
Piotroski VR‑10 (Strict, 0-10) 5.5
| Net Income: 1.22b TTM > 0 and > 6% of Revenue |
| FCF/TA: -0.02 > 0.02 and ΔFCF/TA -2.39 > 1.0 |
| NWC/Revenue: 10.74% < 20% (prev 2.94%; Δ 7.80% < -1%) |
| CFO/TA 0.03 > 3% & CFO 824.8m > Net Income 1.22b |
| Net Debt (483.3m) to EBITDA (2.92b): 0.17 < 3 |
| Current Ratio: 1.32 > 1.5 & < 3 |
| Outstanding Shares: last quarter (294.9m) vs 12m ago -7.41% < -2% |
| Gross Margin: 16.51% > 18% (prev 0.14%; Δ 1637 % > 0.5%) |
| Asset Turnover: 49.29% > 50% (prev 48.52%; Δ 0.77% > 0%) |
| Interest Coverage Ratio: 8.81 > 6 (EBITDA TTM 2.92b / Interest Expense TTM 217.7m) |
Altman Z'' 3.80
| A: 0.05 (Total Current Assets 5.24b - Total Current Liabilities 3.98b) / Total Assets 24.48b |
| B: 0.58 (Retained Earnings 14.18b / Total Assets 24.48b) |
| C: 0.08 (EBIT TTM 1.92b / Avg Total Assets 23.70b) |
| D: 0.98 (Book Value of Equity 12.06b / Total Liabilities 12.25b) |
| Altman-Z'' Score: 3.80 = AA |
Beneish M -3.32
| DSRI: 0.76 (Receivables 1.08b/1.35b, Revenue 11.68b/11.12b) |
| GMI: 0.82 (GM 16.51% / 13.59%) |
| AQI: 1.01 (AQ_t 0.21 / AQ_t-1 0.21) |
| SGI: 1.05 (Revenue 11.68b / 11.12b) |
| TATA: 0.02 (NI 1.22b - CFO 824.8m) / TA 24.48b) |
| Beneish M-Score: -3.32 (Cap -4..+1) = AA |
What is the price of MOS shares?
As of March 03, 2026, the stock is trading at USD 27.51 with a total of 8,418,659 shares traded.
Over the past week, the price has changed by -4.25%, over one month by +0.88%, over three months by +13.87% and over the past year by +21.64%.
Over the past week, the price has changed by -4.25%, over one month by +0.88%, over three months by +13.87% and over the past year by +21.64%.
Is MOS a buy, sell or hold?
The Mosaic has received a consensus analysts rating of 3.85.
Therefore, it is recommended to buy MOS.
- StrongBuy: 5
- Buy: 7
- Hold: 8
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the MOS price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 31.8 | 15.6% |
| Analysts Target Price | 31.8 | 15.6% |
MOS Fundamental Data Overview March 02, 2026
P/E Trailing = 16.3765
P/E Forward = 15.015
P/S = 0.7332
P/B = 0.7312
P/EG = 1.4092
Revenue TTM = 11.68b USD
EBIT TTM = 1.92b USD
EBITDA TTM = 2.92b USD
Long Term Debt = 3.37b USD (from longTermDebt, two quarters ago)
Short Term Debt = 759.9m USD (from shortTermDebt, last quarter)
Debt = 759.9m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 483.3m USD (from netDebt column, last quarter)
Enterprise Value = 9.32b USD (8.84b + Debt 759.9m - CCE 276.6m)
Interest Coverage Ratio = 8.81 (Ebit TTM 1.92b / Interest Expense TTM 217.7m)
EV/FCF = -17.43x (Enterprise Value 9.32b / FCF TTM -534.6m)
FCF Yield = -5.74% (FCF TTM -534.6m / Enterprise Value 9.32b)
FCF Margin = -4.58% (FCF TTM -534.6m / Revenue TTM 11.68b)
Net Margin = 10.46% (Net Income TTM 1.22b / Revenue TTM 11.68b)
Gross Margin = 16.51% ((Revenue TTM 11.68b - Cost of Revenue TTM 9.75b) / Revenue TTM)
Gross Margin QoQ = 14.17% (prev 16.00%)
Tobins Q-Ratio = 0.38 (Enterprise Value 9.32b / Total Assets 24.48b)
Interest Expense / Debt = 5.28% (Interest Expense 40.1m / Debt 759.9m)
Taxrate = 27.37% (61.1m / 223.2m)
NOPAT = 1.39b (EBIT 1.92b * (1 - 27.37%))
Current Ratio = 1.32 (Total Current Assets 5.24b / Total Current Liabilities 3.98b)
Debt / Equity = 0.06 (Debt 759.9m / totalStockholderEquity, last quarter 12.08b)
Debt / EBITDA = 0.17 (Net Debt 483.3m / EBITDA 2.92b)
Debt / FCF = -0.90 (negative FCF - burning cash) (Net Debt 483.3m / FCF TTM -534.6m)
Total Stockholder Equity = 12.27b (last 4 quarters mean from totalStockholderEquity)
RoA = 5.16% (Net Income 1.22b / Total Assets 24.48b)
RoE = 9.96% (Net Income TTM 1.22b / Total Stockholder Equity 12.27b)
RoCE = 12.26% (EBIT 1.92b / Capital Employed (Equity 12.27b + L.T.Debt 3.37b))
RoIC = 8.26% (NOPAT 1.39b / Invested Capital 16.85b)
WACC = 9.00% (E(8.84b)/V(9.60b) * Re(9.44%) + D(759.9m)/V(9.60b) * Rd(5.28%) * (1-Tc(0.27)))
Discount Rate = 9.44% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -5.14%
[DCF] Fair Price = unknown (Cash Flow -534.6m)
EPS Correlation: -84.84 | EPS CAGR: -47.18% | SUE: -3.64 | # QB: 0
Revenue Correlation: -78.84 | Revenue CAGR: -10.35% | SUE: -0.35 | # QB: 0
EPS next Quarter (2026-06-30): EPS=0.33 | Chg7d=-0.189 | Chg30d=-0.215 | Revisions Net=-5 | Analysts=8
EPS current Year (2026-12-31): EPS=1.84 | Chg7d=-0.580 | Chg30d=-0.642 | Revisions Net=-5 | Growth EPS=-19.1% | Growth Revenue=+3.4%
EPS next Year (2027-12-31): EPS=2.44 | Chg7d=-0.070 | Chg30d=-0.174 | Revisions Net=-2 | Growth EPS=+32.8% | Growth Revenue=-0.4%
[Analyst] Revisions Ratio: -1.00 (0 Up / 5 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 3.3% (Discount Rate 9.4% - Earnings Yield 6.1%)
[Growth] Growth Spread = +0.6% (Analyst 4.0% - Implied 3.3%)
P/E Forward = 15.015
P/S = 0.7332
P/B = 0.7312
P/EG = 1.4092
Revenue TTM = 11.68b USD
EBIT TTM = 1.92b USD
EBITDA TTM = 2.92b USD
Long Term Debt = 3.37b USD (from longTermDebt, two quarters ago)
Short Term Debt = 759.9m USD (from shortTermDebt, last quarter)
Debt = 759.9m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 483.3m USD (from netDebt column, last quarter)
Enterprise Value = 9.32b USD (8.84b + Debt 759.9m - CCE 276.6m)
Interest Coverage Ratio = 8.81 (Ebit TTM 1.92b / Interest Expense TTM 217.7m)
EV/FCF = -17.43x (Enterprise Value 9.32b / FCF TTM -534.6m)
FCF Yield = -5.74% (FCF TTM -534.6m / Enterprise Value 9.32b)
FCF Margin = -4.58% (FCF TTM -534.6m / Revenue TTM 11.68b)
Net Margin = 10.46% (Net Income TTM 1.22b / Revenue TTM 11.68b)
Gross Margin = 16.51% ((Revenue TTM 11.68b - Cost of Revenue TTM 9.75b) / Revenue TTM)
Gross Margin QoQ = 14.17% (prev 16.00%)
Tobins Q-Ratio = 0.38 (Enterprise Value 9.32b / Total Assets 24.48b)
Interest Expense / Debt = 5.28% (Interest Expense 40.1m / Debt 759.9m)
Taxrate = 27.37% (61.1m / 223.2m)
NOPAT = 1.39b (EBIT 1.92b * (1 - 27.37%))
Current Ratio = 1.32 (Total Current Assets 5.24b / Total Current Liabilities 3.98b)
Debt / Equity = 0.06 (Debt 759.9m / totalStockholderEquity, last quarter 12.08b)
Debt / EBITDA = 0.17 (Net Debt 483.3m / EBITDA 2.92b)
Debt / FCF = -0.90 (negative FCF - burning cash) (Net Debt 483.3m / FCF TTM -534.6m)
Total Stockholder Equity = 12.27b (last 4 quarters mean from totalStockholderEquity)
RoA = 5.16% (Net Income 1.22b / Total Assets 24.48b)
RoE = 9.96% (Net Income TTM 1.22b / Total Stockholder Equity 12.27b)
RoCE = 12.26% (EBIT 1.92b / Capital Employed (Equity 12.27b + L.T.Debt 3.37b))
RoIC = 8.26% (NOPAT 1.39b / Invested Capital 16.85b)
WACC = 9.00% (E(8.84b)/V(9.60b) * Re(9.44%) + D(759.9m)/V(9.60b) * Rd(5.28%) * (1-Tc(0.27)))
Discount Rate = 9.44% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -5.14%
[DCF] Fair Price = unknown (Cash Flow -534.6m)
EPS Correlation: -84.84 | EPS CAGR: -47.18% | SUE: -3.64 | # QB: 0
Revenue Correlation: -78.84 | Revenue CAGR: -10.35% | SUE: -0.35 | # QB: 0
EPS next Quarter (2026-06-30): EPS=0.33 | Chg7d=-0.189 | Chg30d=-0.215 | Revisions Net=-5 | Analysts=8
EPS current Year (2026-12-31): EPS=1.84 | Chg7d=-0.580 | Chg30d=-0.642 | Revisions Net=-5 | Growth EPS=-19.1% | Growth Revenue=+3.4%
EPS next Year (2027-12-31): EPS=2.44 | Chg7d=-0.070 | Chg30d=-0.174 | Revisions Net=-2 | Growth EPS=+32.8% | Growth Revenue=-0.4%
[Analyst] Revisions Ratio: -1.00 (0 Up / 5 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 3.3% (Discount Rate 9.4% - Earnings Yield 6.1%)
[Growth] Growth Spread = +0.6% (Analyst 4.0% - Implied 3.3%)